← Back to headlines
BridgeBio Settles Patent Dispute with Pfizer
BridgeBio Pharmaceuticals saw gains after reaching a settlement in its patent dispute with Pfizer regarding the drug Vyndamax.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Oil Jumps Above $100 After US-Iran Talks Fail
just now
Serbian Central Bank Hosts EBRD Transition Report Presentation
21m ago
Kittilä Municipality Buys Apartments for One Euro Due to Lack of Bank Loans
23m ago
Suspicious Invoices in Poland's KSeF System Can Now Be Easily Reported to Tax Authorities
24m ago